...
首页> 外文期刊>BMC Health Services Research >A cost analysis of introducing an infectious disease specialist-guided antimicrobial stewardship in an area with relatively low prevalence of antimicrobial resistance
【24h】

A cost analysis of introducing an infectious disease specialist-guided antimicrobial stewardship in an area with relatively low prevalence of antimicrobial resistance

机译:在抗菌素耐药率相对较低的地区引入传染病专家指导的抗菌素管理的成本分析

获取原文
           

摘要

Background Antimicrobial stewardship programs have been widely introduced in hospitals as a response to increasing antimicrobial resistance. Although such programs are commonly used, the long-term effects on antimicrobial resistance as well as societal economics are uncertain. Methods We performed a cost analysis of an antimicrobial stewardship program introduced in Malm?, Sweden in 20?weeks 2013 compared with a corresponding control period in 2012. All direct costs and opportunity costs related to the stewardship intervention were calculated for both periods. Costs during the stewardship period were directly compared to costs in the control period and extrapolated to a yearly cost. Two main analyses were performed, one including only comparable direct costs (analysis one) and one including comparable direct and opportunity costs (analysis two). An extra analysis including all comparable direct costs including costs related to length of hospital stay (analysis three) was performed, but deemed as unrepresentative. Results According to analysis one, the cost per year was SEK 161 990 and in analysis two the cost per year was SEK 5 113. Since the two cohorts were skewed in terms of size and of infection severity as a consequence of the program, and since short-term patient outcomes have been demonstrated to be unchanged by the intervention, the costs pertaining to patient outcomes were not included in the analysis, and we suggest that analysis two provides the most correct cost calculation. In this analysis, the main cost drivers were the physician time and nursing time. A sensitivity analysis of analysis two suggested relatively modest variation under changing assumptions. Conclusion The total yearly cost of introducing an infectious disease specialist-guided, audit-based antimicrobial stewardship in a department of internal medicine, including direct costs and opportunity costs, was calculated to be as low as SEK 5 113.
机译:背景技术抗菌素管理计划已在医院中广泛采用,以应对日益增加的抗菌素耐药性。尽管通常使用此类程序,但对抗菌素耐药性以及社会经济学的长期影响尚不确定。方法我们对2013年在瑞典马尔姆市引入的抗菌药物管理计划进行了成本分析,该计划与2012年的相应控制期相比于2013年的20周进行了计算。在这两个时期内均计算了与管理干预相关的所有直接成本和机会成本。将管理期的成本直接与控制期的成本进行比较,并推断为年度成本。进行了两项主要分析,一项仅包括可比较的直接成本(分析一),另一项包括可比较的直接成本和机会成本(分析二)。进行了包括所有可比较的直接费用在内的额外分析,包括与住院时间相关的费用(分析三),但被认为没有代表性。结果根据分析一,每年的费用为161 990瑞典克朗,而分析二为每年的费用为5 113瑞典克朗。由于该计划的结果,这两个队列在规模和感染严重性方面均存在偏差,干预已证明短期患者预后没有变化,与患者预后有关的费用未包括在分析中,我们建议分析二提供最正确的费用计算。在此分析中,主要的成本动因是医师时间和护理时间。分析二的敏感性分析表明,在不断变化的假设下,变化相对较小。结论在内科中引入传染病专家指导,基于审核的抗菌药物管理的年度总成本(包括直接成本和机会成本)经计算可低至5113瑞典克朗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号